Tarsus Pharmaceuticals, Inc. (TARS)
68.20
-3.88
(-5.38%)
USD |
NASDAQ |
Oct 23, 16:00
68.16
-0.04
(-0.06%)
After-Hours: 20:00
Tarsus Pharmaceuticals Price : 68.20 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 71.48 | 71.70 | 67.65 | 68.20 | 556620.0 |
| Oct 22, 2026 | 70.93 | 73.11 | 69.55 | 72.08 | 688656.0 |
| Oct 21, 2026 | 70.85 | 72.81 | 70.20 | 70.50 | 945911.0 |
| Oct 20, 2026 | 69.54 | 72.46 | 67.93 | 71.03 | 898979.0 |
| Oct 19, 2026 | 68.08 | 70.94 | 68.08 | 69.50 | 682552.0 |
| Oct 16, 2026 | 70.87 | 70.87 | 67.95 | 68.07 | 2.872M |
| Oct 15, 2026 | 72.58 | 74.94 | 70.55 | 70.99 | 1.398M |
| Oct 14, 2026 | 70.57 | 73.35 | 70.03 | 72.29 | 1.167M |
| Oct 13, 2026 | 74.50 | 75.02 | 70.32 | 70.82 | 1.633M |
| Oct 12, 2026 | 73.20 | 76.64 | 72.98 | 74.40 | 1.463M |
| Oct 09, 2026 | 72.22 | 73.93 | 71.20 | 73.16 | 481753.0 |
| Oct 08, 2026 | 73.07 | 74.52 | 70.80 | 72.22 | 642112.0 |
| Oct 07, 2026 | 73.58 | 74.68 | 73.30 | 73.61 | 542285.0 |
| Oct 06, 2026 | 74.48 | 75.26 | 72.94 | 74.11 | 432428.0 |
| Oct 05, 2026 | 73.22 | 75.00 | 72.76 | 74.46 | 939607.0 |
| Oct 02, 2026 | 75.84 | 75.84 | 72.94 | 73.00 | 1.205M |
| Oct 01, 2026 | 78.45 | 79.10 | 75.03 | 75.46 | 1.242M |
| Sep 30, 2026 | 76.76 | 78.70 | 76.32 | 78.61 | 1.563M |
| Sep 29, 2026 | 76.22 | 77.99 | 75.53 | 76.69 | 417967.0 |
| Sep 28, 2026 | 75.83 | 76.82 | 74.66 | 76.81 | 1.310M |
| Sep 25, 2026 | 75.78 | 76.17 | 73.85 | 75.69 | 721440.0 |
| Sep 24, 2026 | 75.33 | 77.91 | 74.44 | 75.96 | 598792.0 |
| Sep 23, 2026 | 77.18 | 77.61 | 74.20 | 74.29 | 674306.0 |
| Sep 22, 2026 | 77.61 | 78.59 | 76.01 | 77.08 | 517016.0 |
| Sep 21, 2026 | 78.09 | 78.57 | 76.39 | 77.46 | 487110.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Bristol Myers Squibb Co. | 61.48 |
| Amneal Pharmaceuticals, Inc. | 20.38 |
| ANI Pharmaceuticals, Inc. | 72.61 |
| Corcept Therapeutics, Inc. | 85.86 |
| Veru, Inc. | 2.24 |
Price Related Metrics
| PS Ratio | 4.829 |
| Price to Book Value | 8.511 |
| Price to Free Cash Flow | 52.29 |
| Earnings Yield | -1.58% |
| Market Cap | 2.951B |